Dominik Kylies

Dominik Kylies is an academic physician-scientist at the University Medical Center Hamburg-Eppendorf, affiliated with the Faculty of Medicine and Department of Nephrology. His research spans multiple disciplines including nephrology, oncology, and medical imaging, with a particular focus on kidney diseases, cancer-related complications, and advanced diagnostic techniques. As evidenced by his publication record, Dr. Kylies collaborates extensively with researchers across multiple institutions and contributes significantly to translational medical research.

Dr. Kylies' research interests primarily center on nephrology with specific focus areas including membranous nephropathy, complement system activation, kidney organoid modeling, and the intersection of kidney disease with cancer. His work also extends to sarcopenia and body composition analysis in cancer patients, particularly examining how muscle wasting affects outcomes in multiple myeloma and osteosarcoma. Additionally, he investigates the role of the microbiome in cancer treatment efficacy and explores advanced imaging techniques for pathology specimen analysis.

Analysis of Dr. Kylies' publication trends reveals a strong focus on translational research bridging basic science and clinical applications. His work spans kidney disease mechanisms, cancer complications, and advanced diagnostic methodologies. Recent publications demonstrate increasing sophistication in multi-omics approaches, spatial biology techniques, and super-resolution imaging. The research shows particular strength in connecting molecular mechanisms (like complement activation or microbiome metabolites) with clinical outcomes in nephrology and oncology.

Dr. Kylies has contributed to significant advancements in understanding kidney disease mechanisms, particularly regarding complement system activation in membranous nephropathy and the role of collagen IV modifications in thin basement membrane disease. His work on sarcopenia in cancer patients has provided important clinical insights for risk stratification in stem cell transplantation. The development of optimized protocols for multiomics processing of kidney tissue represents a technical advancement in the field.

Dr. Kylies collaborates with major research groups including the Center for Inflammation, Infection and Immunity (C3i) and the University Cancer Center Hamburg (UCCH). His research appears to be supported by institutional resources at the University Medical Center Hamburg-Eppendorf, including access to Core Facilities and the Research Information System. His extensive publication record suggests involvement in multiple collaborative research projects across nephrology, oncology, and immunology domains.

Dr. Kylies is affiliated with the Third Medical Clinic and Polyclinic at UKE, which houses specialized research facilities for nephrology and internal medicine. His work appears connected to multiple research networks including the Cardiovascular Research Center (CVRC) and the Center for Health Care Research & Public Health. The collaborative nature of his publications suggests active participation in interdisciplinary research teams focused on kidney disease mechanisms and cancer-related complications.